Biocardia says submitted detailed response fda related to investigational new drug application for bcda-03

Biocardia inc - submitted detailed response fda related to investigational new drug application for bcda-03.biocardia inc - received confirmation that fda received submission on july 2, 2020..

BCDA Ratings Summary

BCDA Quant Ranking